More about

Nivolumab

News
February 27, 2025
4 min watch
Save

VIDEO: Trial builds on current microsatellite instability-high colorectal cancer therapy

VIDEO: Trial builds on current microsatellite instability-high colorectal cancer therapy

In this video, Arvind N. Dasari, MD, MS, discussed the results of the CheckMate 8HW trial in which nivolumab and ipilimumab were compared with nivolumab monotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer.

News
January 11, 2025
1 min read
Save

Adjuvant nivolumab improves DFS in high-risk head and neck cancer

Adjuvant nivolumab improves DFS in high-risk head and neck cancer

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally advanced squamous cell carcinoma of the head and neck.

News
January 02, 2025
1 min read
Save

CAR-T improves PFS for certain patients with gastric, gastroesophageal junction cancers

CAR-T improves PFS for certain patients with gastric, gastroesophageal junction cancers

Satricabtagene autoleucel improved PFS compared with physician’s choice of therapy for patients with Claudin18.2 expression-positive advanced gastric or gastroesophageal junction cancers, according to the agent’s manufacturer.

News
December 27, 2024
1 min read
Save

FDA approves Opdivo as subcutaneous injection

FDA approves Opdivo as subcutaneous injection

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.

News
November 14, 2024
19 min listen
Save

Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release)

Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release)

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

News
October 17, 2024
11 min listen
Save

Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of October 14, 2024

Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of October 14, 2024

In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more.

News
October 16, 2024
5 min read
Save

Nivolumab regimen halves risk for progression, death in Hodgkin lymphoma

Nivolumab regimen halves risk for progression, death in Hodgkin lymphoma

Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.

News
October 03, 2024
1 min read
Save

FDA approves Opdivo regimen for resectable NSCLC

FDA approves Opdivo regimen for resectable NSCLC

The FDA expanded the approval of nivolumab for treatment of non-small cell lung cancer.

News
October 02, 2024
19 min listen
Save

Highlights from 2024 World Conference on Lung Cancer

Highlights from 2024 World Conference on Lung Cancer

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

News
September 19, 2024
14 min listen
Save

Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of September 16, 2024

Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of September 16, 2024

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more.

View more